Ivermectin Stada (Ivermectin)

Ivermectin binds to glutamate‑gated chloride channels that are present in invertebrate nerve and muscle cells. This binding opens the channels, allowing an influx of chloride ions, which hyperpolarises the cells, causing paralysis and death of the parasite while sparing human cells that lack these channels.

The exact dose of Ivermectin Stada is determined by the prescribing clinician based on the specific indication, patient weight, age, and any relevant comorbidities. Dosage regimens are individualized and should follow the latest clinical guidelines or the prescriber’s judgment.

Safety data for Ivermectin Stada in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless the potential benefit justifies the risk. For breastfeeding mothers, the decision should be made after weighing the infant’s exposure against the mother’s therapeutic need.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Ivermectin offers a broad spectrum of activity against both nematodes and ectoparasites, often requiring a single oral dose, whereas many alternative agents may need multiple doses or different routes of administration. Its safety profile is favorable, but drug‑specific interactions and resistance patterns should be considered when selecting therapy.

Ivermectin Stada should be stored below 25 °C in its original packaging. Protect the product from moisture, direct sunlight and excessive heat to maintain potency throughout its shelf life.

Ivermectin Stada is taken orally, usually with water. The tablet (or other oral form) is swallowed whole and should be taken on an empty stomach unless the prescriber advises otherwise. The exact timing and any food restrictions are determined by the treating physician.

Serious adverse events, though rare, include severe skin reactions such as Stevens‑Johnson syndrome, hepatotoxicity, neurologic complications like seizures or ataxia, and anaphylactic reactions. Patients should be monitored for any signs of these conditions and seek immediate medical attention if they occur.

Ivermectin Stada is contraindicated in individuals with known hypersensitivity to ivermectin or any excipients in the formulation. Caution is also advised for patients with severe hepatic impairment, those taking strong CYP3A4 inhibitors, and pregnant women unless the therapeutic benefit outweighs potential risks.